LGSN and gastric cancer: To further assess whether LGSN could be a safe and potential target for GC therapy, we performed systemic treatment in nude mice bearing GCSC xenografts via tail vein injection of GFP-tagged AAV-shLGSN and AAV–shNTC, respectively.